For instance, in a T2DM mouse model induced by HFD/STZ, 8-week Rg1 treatment reduces urinary protein, serum creatinine, and blood urea nitrogen levels by inhibiting CD36/TRPC6/NFAT2 signaling (Han et al., 2023). The gene discussed is TRPC6; the disease is type 2 diabetes mellitus.